Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Gc, Passali"'
Autor:
Desiderio Passali, Michele Loglisci, Cristina Iosif, Gc Passali, Francesco Maria Passali, Codrut Sarafoleanu, Luisa Bellussi, Claudiu Manea
Publikováno v:
Acta Otorhinolaryngologica Italica. 38:225-228
The aim of this research is to investigate penetration of Bromelain into sinonasal mucosa in patients with chronic rhinosinusitis (CRS) versus a control group. Bromelain is derived from pineapple (Ananas comosus) and has various pharmacological effec
Autor:
E. De Corso, G.C. Mattiucci, Gc Passali, Valentina Lancellotta, M.A. Gambacorta, G Paludetti, G. Di Cintio, Francesco Bussu, Bruno Fionda, Davide Rizzo, F. Deodato, V. Valentini, J Galli, Antonio Salvati, Luca Tagliaferri
Publikováno v:
Radiotherapy and Oncology. 152:S426-S427
Autor:
Roberta Anzivino, Bruno S. Sergi, Alfonso Fasano, L. Vargiu, Gaetano Paludetti, Gc Passali, Anna Rita Bentivoglio, Jacopo Galli, Francesco Bove, Mario Rigante, M. Giuliani, Francesca Cianfrone, E. De Corso, Manlio Pandolfini
Objectives to investigate in Parkinson's Disease affected patients a correlation between hyposmia and gastrointestinal dysfunction and their possible identical etiopathogenesis. Design retrospective cohort study. Setting ENT and Neurology departments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f1b0919101af551852b75338bf3e790
http://hdl.handle.net/11391/1446026
http://hdl.handle.net/11391/1446026
Autor:
Gc Passali, G.C. Mattiucci, G. Di Cintio, V. Valentini, Giovanni Almadori, Francesco Bussu, Luca Tagliaferri, N. Dinapoli, J Galli, E. De Corso, G Paludetti
Publikováno v:
Radiotherapy and Oncology. 123:S983-S984
Autor:
Silvano Esposito, Gc Passali, Teresita Mazzei, Valerio Damiani, Luisa Bellussi, Desiderio Passali, Francesco Maria Passali
Publikováno v:
International Congress Series. 1257:253-256
Purpose : To evaluate modifications of moxifloxacin (MFX) concentrations in tonsillar tissue and plasma up to 24 h after three oral doses of 400 mg, and to assess the safety and tolerability of this drug in adult patients with chronic or recurrent to
Publikováno v:
Oto-Rhino-Laryngologia Nova. 12:71-76
The therapeutic rationale of acute or chronic rhinosinusal inflammatory disease must necessarily be based on the correct identification of the microbiological agents involved in causing the sinus affection. In our experience, Streptococcus pneumoniae
Publikováno v:
Clinical and Applied Immunology Reviews. 1:207-216
Even though not a life-threatening disease, allergic rhinitis has a prevalence over 10% of the total population all over the world with a remarkable social impact and cannot be left to its natural course. Its natural history, that starts with the mee
Publikováno v:
Europe PubMed Central
Sublingual immunotherapy with monomeric allergoid, given according to the standard schedule, was reported to be effective and safe in many clinical trials. However, a long period of time may elapse before achievement of a clinical benefit. This study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a440ecfb062f6fb810972dcadecd351e
http://hdl.handle.net/2108/22522
http://hdl.handle.net/2108/22522
Autor:
Passali D, Fiorella R, Camaioni A, Villari G, Mora E, Gc, Passali, Fm, Passali, Crisanti A, Bellussi L
Publikováno v:
Europe PubMed Central
The aim of our study was to evaluate the efficacy of 30 days treatment with glucan solution nasal spray vs. saline in the treatment of signs and symptoms of chronic rhinosinusitis.100 patients affected by chronic rhinosinusitis were enrolled. At the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bba2704e003c4b56d48676fb8efaf333
http://hdl.handle.net/11365/35970
http://hdl.handle.net/11365/35970
Publikováno v:
Europe PubMed Central
The aim of the current study is to underline once again the etiopathogenetic aspects of rhinosinusitis, by a revision of most significative and updated study in otorhinolaryngologic literature to guide the right management of this disease. The focal